<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: The adult non-<z:mp ids='MP_0001261'>obese</z:mp> Goto-Kakizaki (GK) rat model of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, particularly females, carries in addition to <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> a genetic predisposition towards <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidaemia</z:e>, including <z:e sem="disease" ids="C0020443" disease_type="Disease or Syndrome" abbrv="">hypercholesterolaemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>As cholesterol-induced <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> may be programmed in utero, we looked for signs of perinatal <z:chebi fb="23" ids="18059">lipid</z:chebi> alterations and islet <z:e sem="disease" ids="C0155765" disease_type="Disease or Syndrome" abbrv="">microangiopathy</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We hypothesise that such alterations contribute towards defective pancreas/islet vascularisation that might, in turn, lead to decreased beta cell mass </plain></SENT>
<SENT sid="3" pm="."><plain>Accordingly, we also evaluated islet <z:mp ids='MP_0001845'>inflammation</z:mp> and endothelial activation in both <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetic</z:e> and diabetic animals </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: Blood, liver and pancreas were collected from embryonic day (E)21 fetuses, 7-day-old <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetic</z:e> neonates and 2.5-month-old diabetic GK rats and Wistar controls for analysis/quantification of: (1) systemic variables, particularly <z:chebi fb="23" ids="18059">lipids</z:chebi>; (2) cholesterol-linked hepatic enzyme <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression and/or activity; (3) pancreas (fetuses) or collagenase-isolated islet (neonates/adults) gene expression using Oligo GEArray microarrays targeted at rat endothelium, <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> biomarkers and <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>, and/or RT-PCR; and (4) pancreas endothelial immunochemistry: nestin (fetuses) or <z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">von Willebrand</z:e> factor (neonates) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Systemic and hepatic cholesterol anomalies already exist in GK fetuses and neonates </plain></SENT>
<SENT sid="6" pm="."><plain>Hyperglycaemic GK fetuses exhibit a similar percentage decrease in total pancreas and islet vascularisation and beta cell mass </plain></SENT>
<SENT sid="7" pm="."><plain>Normoglycaemic GK neonates show systemic <z:mp ids='MP_0001845'>inflammation</z:mp>, signs of islet pre-<z:e sem="disease" ids="C0155765" disease_type="Disease or Syndrome" abbrv="">microangiopathy</z:e>, disturbed <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>, collapsed vascularisation and altered pancreas development </plain></SENT>
<SENT sid="8" pm="."><plain>Concomitantly, GK neonates exhibit elevated defence mechanisms </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS/INTERPRETATION: These data suggest an autoinflammatory disease, triggered by in utero programming of cholesterol-induced islet <z:e sem="disease" ids="C0155765" disease_type="Disease or Syndrome" abbrv="">microangiopathy</z:e> interacting with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> in GK rats </plain></SENT>
<SENT sid="10" pm="."><plain>During the perinatal period, GK rats show also a marked deficient islet vascularisation in conjunction with decreased beta cell mass </plain></SENT>
</text></document>